Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients

    Home News OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients
    NextPrevious

    OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients

    By sarah | News | 0 comment | 4 October, 2019 | 0

    By Scott Meacham

    Lupus is chronic autoimmune condition with devastating effects. The disease is difficult to diagnose. Its course is unpredictable. There is no cure and few FDA-approved medications. Patients who have lupus live with its impact for the rest of their lives.

    At times, the disease flares up and gets worse; in remission, symptoms get better or temporarily disappear. Periods of intense lupus symptoms, known as disease flares or flare-ups, can seem to appear at random. These episodes may start with fatigue and fever, joint pain, headaches, confusion and memory loss. They often progress to kidney damage and inflammation throughout the body, as the lupus patient’s immune system attacks the body’s healthy cells

    A patient with lupus doesn’t know when a flare is going to occur, so in addition to the physical toll, it is a weighty mental burden, never knowing when or where the pain will start.

    Progentec Diagnostics, with licensed technology from the Oklahoma Medical Research Foundation (OMRF), is developing new solutions to bring greater consistency to the lives of people with lupus.

    “The patient comes first,” said Mohan Purushothaman, Ph.D., President, and CEO of Progentec. “Our platform is carefully crafted to help people with lupus at every step of the patient journey. From identification and diagnosis to symptom and medication management, Progentec offers people with lupus the right tool at the right moment to take charge of their health.”

    Progentec’s aim to radically improve lupus care starts with bringing predictability to the natural cycles of the disease. A one-of-its-kind blood biomarker test can alert patients and their rheumatologists to the risk of a flare three months in the future. Armed with this knowledge, patients and clinicians can take active steps to reduce the severity of the flare, preserving organs and limiting the impact of lupus.

    In addition to the flare prediction test, Progentec is also developing biomarker tests for the diagnosis of lupus and the measurement of disease activity levels. Today, about one-third of people report seeing more than six doctors before being diagnosed. Progentec is working with the Mayo Clinic and has received research funding from the National Institutes of Health for the development of lab tests to reduce the time it takes to get a patient on the right treatment plan.

    Progentec’s focus on the patient doesn’t stop with innovative laboratory testing. The company also offers powerful digital tools that support the day-to-day challenges of lupus. The LupusCorner platform, which is used by nearly 65,000 people, provides free access to symptom and medication management tools, health literacy information, and a community forum. All designed for the smartphone, LupusCorner makes it easy to track symptoms, identify personal lupus triggers, and share information with a clinician.

    The pharmaceutical industry is showing some interest in creating new products for lupus, but in the interim, lupus patients want to go to work, raise their families, and contribute to their communities. They want to live their lives.

    Progentec is redefining the management of chronic conditions with laboratory tests and tools to help people with lupus do just that. Lupus can interfere with the lives of patients in many ways. Now patients have multiple ways to fight back.

    Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Meacham at i2E_Comments@i2E.org

    Lupus, Lupus Corner, Mohan Purushothaman, OMRF, Progentec Diagnostics, Scott Meacham

    Related Posts

    • i2E investment an important validation of technology developed by OKC’s Progentec Diagnostics

      By sarah | 0 comment

      By Scott Meacham As i2E has been closing our latest round of new investments over the last few weeks, I am reminded of how in the startup world and the venture industry, investment events attractRead more

    • Innovation & Entrpreneurs: Serial entrepreneurs launch own diagnostics-focused company in state

      By admin | 0 comment

      I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.

    • OKC-based Progentec Diagnostics refines test to predict future lupus flares

      By sarah | 0 comment

      By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still anotherRead more

    • Progentec Diagnostics Raises Funds to Support Advances in Lupus Detection and Management

      By sarah | 0 comment

      – New funding brings lupus-detection tools closer to commercialization  – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), aRead more

    • Oklahoma Medical Research Foundation a valuable contributor medically — and economically

      By sarah | 0 comment

      By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identifyRead more

    Leave a Comment

    Cancel reply

    Your email address will not be published. Required fields are marked *

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Library
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592
    Click HERE for printable map with directions.
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About i2E
    • Services
    • Investments
    • Development
      • Love’s Cup
        • Forms
        • High Growth
        • Small Business
        • Timeline
    • Portfolio 3
    • Contact
    i2E